Back to all Representative Matters
May 10, 2019
Eve & Co Completes $10.45 Million Special Warrant Bought Deal Private Placement
On May 10, 2019, Eve & Co Incorporated (TSX-V: EVE) completed a bought deal private placement of 20,900,000 special warrants at a price of $0.50 per special warrant for aggregate gross proceeds of $10,450,000. Eve & Co intends to use the net proceeds for greenhouse expansion and for working capital and general corporate purposes. Haywood Securities Inc. acted as underwriter.
Eve & Co, through its wholly-owned subsidiary Natural MedCo Ltd., holds cultivation and processing licences under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and cannabis oil. Natural MedCo Ltd. was Canada’s first female founded licensed producer of medicinal marijuana and received its cultivation license from Health Canada in 2016.
Aird & Berlis LLP represented Eve & Co with a team comprised of Richard Kimel, Melanie Cole and Sean Green (Capital Markets).